NH - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

IntraDay Trade Rating: 4.0

💹 Optimal Buy Price: ₹1,820–₹1,825 (near 50 DMA and short-term support)

🎯 Profit Target: ₹1,860–₹1,875 (minor resistance zone)

🛡️ Stop Loss: ₹1,800 (below 50 DMA and psychological support)

📊 Exit Strategy if Already Holding: Consider exiting near ₹1,870 if RSI approaches 63 and MACD flattens. Watch for price rejection near ₹1,875 and volume spikes.

✅ Positive

• 📈 RSI at 60.4 and MACD at 6.28 indicate bullish momentum
• 📊 Volume today (9.88L) is significantly above 1-week average (5.27L)
• 📈 Trading above both 50 DMA and 200 DMA, confirming technical strength
• 📉 Debt-to-equity ratio of 0.73 reflects moderate leverage
• 📈 ROCE of 19.4% and ROE of 21.0% show strong capital efficiency

⚠️ Limitation

• 📉 High P/E of 86.5 vs industry average of 57.2 suggests overvaluation
• 📉 DII holding declined by 0.33%
• 📉 PAT dropped from ₹160 Cr to ₹87.4 Cr sequentially
• 📉 PEG ratio of 1.87 indicates expensive growth valuation

🚫 Company Negative News

• 📉 No major negative news reported recently

📢 Company Positive News

• 📈 EPS of ₹21.1 and consistent dividend payout (0.25%)
• 📊 Price action near 52-week midpoint (54.4% index) shows potential for upward movement

🏭 Industry

• 🏥 NH operates in the healthcare services sector, which remains defensive and demand-resilient
• 📈 Industry P/E of 57.2 supports long-term valuation potential

🧾 Conclusion

📌 NH presents a favorable intraday setup today with strong momentum, volume surge, and technical support above key moving averages. Traders may consider entering near ₹1,823 with a target of ₹1,870 and stop loss at ₹1,800. If already holding, monitor RSI and MACD for exit signals near resistance.

I can also help you compare NH’s setup with other healthcare service stocks like Apollo Hospitals or KIMS for sharper intraday opportunities.